According to a recent report by the Centers for Medicare and Medicaid Services (CMS), doctors and hospitals received even more money in 2018 from pharmaceutical…
In February 2019, the FDA warned that the gout medication Uloric (febuxostat), manufactured by Takeda Pharmaceuticals, created an increased risk of death from all causes.…
For about 20 years, the FDA has allowed some medical device manufacturers to shield reports of problems with their devices from the public eye. This…
Pharmaceutical company Takeda recently suffered a blow when the FDA determined that their medication, Uloric (febuxostat), should no longer be recommended as a first-line treatment…
When the FDA first approved the gout medication Uloric (febuxostat) in 2009, they required a warning be placed on the label that alerted doctors and…
The FDA recently warned that patients with rheumatoid arthritis (RA) who are taking the 10 mg twice-daily dose of tofacitinib (Xeljanz, Xeljanz XR) may be…
On February 21, 2019, the FDA released a new safety communication concerning the gout medication, Uloric (febuxostat), manufactured by Takeda Pharmaceuticals. This was an update…
On March 4, 2019, the FDA announced that Apotex—a Weston, Florida company—is voluntarily recalling four lots of Drospirenone and Ethinyl Estradiol birth control tablets. The…
When their 21-year-old daughter died unexpectedly in 2008, shortly after receiving the Gardasil human papillomavirus (HPV) vaccine, the Tarsell family blamed the vaccine for the…
On November 29, 2018, the FDA warned about a rare but serious life-threatening risk of stroke and artery rupture in patients taking the multiple sclerosis…